Capula Management »

Protalix Biotherapeutics shares owned by Capula Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Capula Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $40k 16k 2.56

More positions owned by Capula Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Strategy Cl A New Put Option (MSTR)
UnitedHealth Put Option (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Coinbase Global Com Cl A Call Option (COIN)
Apple (AAPL)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Nike CL B (NKE)
Dell Technologies CL C (DELL)

View all positions for Capula Management

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
Stratos Wealth Partners
State Street Corporation
Vanguard Group
Connor, Clark & Lunn Investment Management
UBS Group
Bridgeway Capital Management
Diametric Capital
Charles Schwab Investment Management
Commonwealth Equity Services
Evergreen Capital Management

View all funds holding Protalix Biotherapeutics